oxybutynin and glucagon

oxybutynin has been researched along with glucagon in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	3 (60.00)	2.80

Authors

Authors	Studies
Branigan, D; Castle, JR; Cummins, M; Newswanger, B; Prestrelski, S; Shi, L; Strange, P; Youssef, JE	1
GhavamiNejad, A; Giacca, A; Lam, L; Li, J; Lu, B; Wu, XY; Zhou, L	1
Buse, JB; Chen, G; Gu, Z; Kahkoska, AR; Li, H; Miedema, JR; Wang, J; Wang, Z; Wen, D; Wu, V; Yu, J; Zeng, Y	1
GhavamiNejad, A; Giacca, A; Liu, JF; Lu, B; Mirzaie, S; Pereira, S; Samarikhalaj, M; Wu, XY; Zhou, L	1
Fu, R; Gu, Z; Han, X; Li, S; Wang, Z; Wen, D; Wu, Y	1

Trials

1 trial(s) available for oxybutynin and glucagon

Article	Year
Comparative Pharmacokinetic/Pharmacodynamic Study of Liquid Stable Glucagon Versus Lyophilized Glucagon in Type 1 Diabetes Subjects. Journal of diabetes science and technology, 2016, Volume: 10, Issue:5 Topics: Adult; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Gastrointestinal Agents; Glucagon; Humans; Hypoglycemic Agents; Insulin; Insulin Infusion Systems; Male; Middle Aged; Transdermal Patch; Young Adult	2016

Article

Year

Comparative Pharmacokinetic/Pharmacodynamic Study of Liquid Stable Glucagon Versus Lyophilized Glucagon in Type 1 Diabetes Subjects.

Journal of diabetes science and technology, 2016, Volume: 10, Issue:5

Topics: Adult; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Gastrointestinal Agents; Glucagon; Humans; Hypoglycemic Agents; Insulin; Insulin Infusion Systems; Male; Middle Aged; Transdermal Patch; Young Adult

2016

Other Studies

4 other study(ies) available for oxybutynin and glucagon

Article	Year
Glucose-Responsive Composite Microneedle Patch for Hypoglycemia-Triggered Delivery of Native Glucagon. Advanced materials (Deerfield Beach, Fla.), 2019, Volume: 31, Issue:30 Topics: Animals; Blood Glucose; Cross-Linking Reagents; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Liberation; Gels; Glucagon; Humans; Hyaluronic Acid; Hypoglycemia; Hypoglycemic Agents; Insulin; Methacrylates; Needles; Photochemical Processes; Polymerization; Rats; Transdermal Patch	2019
Dual self-regulated delivery of insulin and glucagon by a hybrid patch. Proceedings of the National Academy of Sciences of the United States of America, 2020, 11-24, Volume: 117, Issue:47 Topics: Animals; Blood Glucose; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Combinations; Drug Compounding; Drug Delivery Systems; Drug Liberation; Drug Overdose; Glucagon; Humans; Hypoglycemic Agents; Insulin; Male; Mice; Polymerization; Solubility; Streptozocin; Transdermal Patch	2020
Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia prevention. Drug delivery and translational research, 2022, Volume: 12, Issue:4 Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Delivery Systems; Glucagon; Humans; Hypoglycemia; Insulin; Needles; Polymers; Rats; Receptors, Somatostatin; Technology; Transdermal Patch	2022
Shrinking Fabrication of a Glucose-Responsive Glucagon Microneedle Patch. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022, Volume: 9, Issue:28 Topics: Animals; Biocompatible Materials; Diabetes Mellitus; Glucagon; Glucose; Hypoglycemia; Insulin; Mice; Transdermal Patch	2022